Different factors influencing the expression of raynaud's phenomenon in men and women

Arthritis and Rheumatism

Volumn 42, Issue 2, 1999, Pages 306-310

  Fraenkel, Liana ^a,c   Zhang, Yuqing ^a   Chaisson, Christine E ^a   Maricq, Hildegard R ^d   Evans, Stephen R ^a   Brand, Fred ^b   Wilson, Peter W F ^b   Felson, David T ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Blood Inst's F   (United States)

^c Arthritis Center   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL CONSUMPTION; ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RISK FACTOR; SMOKING;

AGE FACTORS; ALCOHOL DRINKING; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MARITAL STATUS; MASSACHUSETTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; RAYNAUD DISEASE; RISK FACTORS; SEX DISTRIBUTION; SMOKING;

EID: 0032968141     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199902)42:2<306::AID-ANR13>3.0.CO;2-G     Document Type: Article

References (16)

1. Planchon B, Pistorius MA, Beurrier P, de Faucal P. Primary Raynaud's phenomenon: age of onset and pathogenesis in a prospective study of 424 patients. Angiology 1994;45:677-86.
2. Cooke JP, Creager MA, Osmundson PJ, Shepherd JT. Sex differences in control of cutaneous blood flow. Circulation 1990;82: 1607-15.
3. Fraenkel L, Zhang Y, Chaisson CE, Evans SR, Wilson PWF, Felson DT. The association of estrogen replacement therapy and Raynaud's phenomenon in post-menopausal women. Ann Intern Med 1998;129:208-11.
4. Feinleib M, Kannel WB, Garrison RJ, McNamara PM, Castelli WP. The Framingham Offspring Study: design and preliminary data. Prev Med 1975;4:518-25.
5. Maricq HR, Weinrich MC. Diagnosis of Raynaud's phenomenon assisted by color charts. J Rheumatol 1988;15:454-9.
6. Brennan P, Silman A, Black C, Bernstein R, Coppock J, Maddison P, et al. Validity and reliability of three methods used in the diagnosis of Raynaud's phenomenon. Br J Rheumatol 1993;32: 357-61.
7. Keil JE, Maricq HR, Weinrich MC, McGregor AR, Diat F. Demographic, social, and clinical correlates of Raynaud phenomenon. Int J Epidemiol 1991;19:221-4.
8. Felson DT, Zhang Y, Hannan MT, Kannel WB, Kiel DP. Alcohol intake and bone mineral density in elderly men and women: The Framingham Study. Am J Epidemiol 1995;142:485-92.
9. O'Keeffe ST, Tsapatsaris NP, Beetham WP. Color chart assisted diagnosis of Raynaud's phenomenon in an unselected hospital employee population. J Rheumatol 1992;19:1415-7.
10. Valter I, Maricq HR. Prevalence of Raynaud's phenomenon in 2 ethnic groups in the general population of Estonia. J Rheumatol 1998;25:697-702.
11. Heslop J, Coggon D, Acheson ED. The prevalence of intermittent digital ischaemia (Raynaud's phenomenon) in a general practice. J R Coll Gen Pract 1983;33:85-9.
12. Harada N, Ueda A, Takegata S. Prevalence of Raynaud's phenomenon in Japanese males and females. J Clin Epidemiol 1991;44:649-55.
13. Silman A, Holligan S, Brennan P, Maddison P. Prevalence of symptoms of Raynaud's phenomenon in general practice. BMJ 1990;301:590-2.
14. Olsen N, Nielsen SL. Prevalence of primary Raynaud phenomena in young females. Scand J Clin Lab Invest 1978;38:761-4.
15. Leppert J, Aberg H, Ringqvist I, Sorensson S. Raynaud's phenomenon in a female population: prevalence and association with other conditions. Angiology 1987;38:871-7.
16. Goodfield MJD, Hume A, Rowell NR. The acute effects of cigarette smoking on cutaneous blood flow in smoking and non-smoking subjects with and without Raynaud's phenomenon. Br J Rheumatol 1990;29:89-91.